Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Erratum to: Functional Analysis of Membrane Proteins Produced by Cell-Free Translation.

Kastenschmidt JM, Avetyan I, Villalta SA.

Methods Mol Biol. 2018;1687:E1. doi: 10.1007/978-1-4939-7374-3_20. No abstract available.

PMID:
29427267
2.

Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry.

Kastenschmidt JM, Avetyan I, Villalta SA.

Methods Mol Biol. 2018;1687:43-56. doi: 10.1007/978-1-4939-7374-3_4. Erratum in: Methods Mol Biol. 2018;1687:E1.

3.

Identification of IL-40, a Novel B Cell-Associated Cytokine.

Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, Villalta SA, Ushach I, Pone EJ, Casali P, Raffatellu M, Burkhardt AM, Hernandez-Ruiz M, Heller G, Hevezi PA, Zlotnik A.

J Immunol. 2017 Nov 1;199(9):3326-3335. doi: 10.4049/jimmunol.1700534. Epub 2017 Oct 4.

4.

Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes.

Morita S, Villalta SA, Feldman HC, Register AC, Rosenthal W, Hoffmann-Petersen IT, Mehdizadeh M, Ghosh R, Wang L, Colon-Negron K, Meza-Acevedo R, Backes BJ, Maly DJ, Bluestone JA, Papa FR.

Cell Metab. 2017 May 2;25(5):1207. doi: 10.1016/j.cmet.2017.04.026. No abstract available.

5.

Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes.

Morita S, Villalta SA, Feldman HC, Register AC, Rosenthal W, Hoffmann-Petersen IT, Mehdizadeh M, Ghosh R, Wang L, Colon-Negron K, Meza-Acevedo R, Backes BJ, Maly DJ, Bluestone JA, Papa FR.

Cell Metab. 2017 Apr 4;25(4):883-897.e8. doi: 10.1016/j.cmet.2017.03.018. Erratum in: Cell Metab. 2017 May 2;25(5):1207.

6.

The immune system in Duchenne muscular dystrophy: Friend or foe.

Villalta SA, Rosenberg AS, Bluestone JA.

Rare Dis. 2015 Feb 23;3(1):e1010966. doi: 10.1080/21675511.2015.1010966. eCollection 2015.

7.

FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle.

Chen S, Villalta SA, Agrawal DK.

J Bone Miner Res. 2016 Mar;31(3):585-95. doi: 10.1002/jbmr.2729. Epub 2015 Nov 9.

8.

Immune-mediated pathology in Duchenne muscular dystrophy.

Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, Wakefield LM, Woodcock J.

Sci Transl Med. 2015 Aug 5;7(299):299rv4. doi: 10.1126/scitranslmed.aaa7322. Review.

9.

Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.

Villalta SA, Rosenthal W, Martinez L, Kaur A, Sparwasser T, Tidball JG, Margeta M, Spencer MJ, Bluestone JA.

Sci Transl Med. 2014 Oct 15;6(258):258ra142. doi: 10.1126/scitranslmed.3009925.

10.

Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.

Villalta SA, Lang J, Kubeck S, Kabre B, Szot GL, Calderon B, Wasserfall C, Atkinson MA, Brekken RA, Pullen N, Arch RH, Bluestone JA.

Diabetes. 2013 Aug;62(8):2870-8. doi: 10.2337/db12-1619. Epub 2013 Jul 8.

11.

IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration.

Deng B, Wehling-Henricks M, Villalta SA, Wang Y, Tidball JG.

J Immunol. 2012 Oct 1;189(7):3669-80. Epub 2012 Aug 29.

12.

IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Villalta SA, Deng B, Rinaldi C, Wehling-Henricks M, Tidball JG.

J Immunol. 2011 Nov 15;187(10):5419-28. doi: 10.4049/jimmunol.1101267. Epub 2011 Oct 17.

13.

Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.

Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, Tidball JG.

Hum Mol Genet. 2011 Feb 15;20(4):790-805. doi: 10.1093/hmg/ddq523. Epub 2010 Nov 30.

14.

Regulatory interactions between muscle and the immune system during muscle regeneration.

Tidball JG, Villalta SA.

Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1173-87. doi: 10.1152/ajpregu.00735.2009. Epub 2010 Mar 10. Review.

15.

NO may prompt calcium leakage in dystrophic muscle.

Tidball JG, Villalta SA.

Nat Med. 2009 Mar;15(3):243-4. doi: 10.1038/nm0309-243. No abstract available.

PMID:
19265820
16.

Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.

Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG.

Hum Mol Genet. 2009 Feb 1;18(3):482-96. doi: 10.1093/hmg/ddn376. Epub 2008 Nov 7.

17.

Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.

Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ.

J Immunol. 2008 Oct 15;181(8):5598-605.

18.

Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.

Wehling-Henricks M, Sokolow S, Lee JJ, Myung KH, Villalta SA, Tidball JG.

Hum Mol Genet. 2008 Aug 1;17(15):2280-92. doi: 10.1093/hmg/ddn129. Epub 2008 Apr 21.

19.

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.

Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC.

J Clin Invest. 2007 Apr;117(4):889-901. Epub 2007 Mar 22.

20.

Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice.

Wolters PJ, Mallen-St Clair J, Lewis CC, Villalta SA, Baluk P, Erle DJ, Caughey GH.

Clin Exp Allergy. 2005 Jan;35(1):82-8.

21.

Mast cell dipeptidyl peptidase I mediates survival from sepsis.

Mallen-St Clair J, Pham CT, Villalta SA, Caughey GH, Wolters PJ.

J Clin Invest. 2004 Feb;113(4):628-34.

Supplemental Content

Loading ...
Support Center